[1] |
李仁忠, 阮云洲, 许琳, 等. 耐多药结核病患者关怀服务操作手册. 北京: 人民卫生出版社, 2021:9-10.
|
[2] |
文书琴. 耐药结核病患者治疗结局的健康社会决定因素分析:双向队列研究. 济南:山东大学, 2021.
|
[3] |
中华人民共和国卫生部. 结核病防治管理办法.2013-07-03.
|
[4] |
徐彩红, 周向梅, 范伟兴, 等. 我国结核病防治主要成就回眸及亟待解决的问题与建议. 中国防痨杂志, 2020, 42(12):1263-1267. doi:10.3969/j.issn.1000-6621.2020.12.002.
doi: 10.3969/j.issn.1000-6621.2020.12.002.
|
[5] |
张宏伟, 许静, 马煜, 等. 陕西省基本公共卫生结核病患者健康管理服务项目实施效果评价. 中国防痨杂志, 2019, 41(9):951-956. doi:10.3969/j.issn.1000-6621.2019.09.008.
doi: 10.3969/j.issn.1000-6621.2019.09.008.
|
[6] |
Deshmukh RD, Dhande DJ, Sachdeva KS, et al. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian J Tuberc, 2018, 65(1):41-47. doi:10.1016/j.ijtb.2017.05.003.
doi: 10.1016/j.ijtb.2017.05.003.
URL
|
[7] |
Paz-Soldán VA, Alban RE, Jones CD, et al. The provision of and need for social support among adult and pediatric patients with tuberculosis in Lima, Peru: a qualitative study. BMC Health Serv Res, 2013, 13:290. doi:10.1186/1472-6963-13-290.
doi: 10.1186/1472-6963-13-290
pmid: 23899353
|
[8] |
Loveday M, Wallengren K, Brust J, et al. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis, 2015, 19(2):163-171. doi:10.5588/ijtld.14.0369.
doi: 10.5588/ijtld.14.0369
pmid: 25574914
|
[9] |
赵阿利, 袁荣, 罗卉, 等. 以患者为中心的耐多药/利福平耐药结核病患者关怀服务实施效果分析. 中国防痨杂志, 2021, 43(6):606-611. doi:10.3969/j.issn.1000-6621.2021.06.015.
doi: 10.3969/j.issn.1000-6621.2021.06.015.
|
[10] |
Walker IF, Shi O, Hicks JP, et al. Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients. Eur Respir J, 2019, 54(1):1800353. doi:10.1183/13993003.00353-2018.
doi: 10.1183/13993003.00353-2018.
URL
|
[11] |
中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019, 41(10):1025-1073. doi:10.3969/j.issn.1000-6621.2019.10.001.
doi: 10.3969/j.issn.1000-6621.2019.10.001.
|
[12] |
尤媛媛, 张国龙, 陈裕. 120例初治耐多药肺结核患者治疗依从性的影响因素分析. 中国防痨杂志, 2020, 42(3):249-254. doi:10.3969/j.issn.1000-6621.2020.03.013.
doi: 10.3969/j.issn.1000-6621.2020.03.013.
|
[13] |
连展, 王婷萍, 杜鹃. 武汉市涂阳肺结核患者药物治疗依从性的影响因素分析. 中国防痨杂志, 2018, 40(2):222-225. doi:10.3969/j.issn.1000-6621.2018.02.022.
doi: 10.3969/j.issn.1000-6621.2018.02.022.
|
[14] |
Atif M, Bashir A, Ahmad N, et al. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. BMC Infect Dis, 2017, 17(1):655. doi:10.1186/s12879-017-2746-5.
doi: 10.1186/s12879-017-2746-5
pmid: 28962599
|
[15] |
李玥璐, 念伟. 结核病患者服药依从性与家庭关怀度的相关性研究. 中华现代护理杂志, 2018, 24(20):2369-2371. doi:10.3760/cma.j.issn.1674-2907.2018.20.004.
doi: 10.3760/cma.j.issn.1674-2907.2018.20.004.
|
[16] |
Nellums LB, Rustage K, Hargreaves S, et al. Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis. BMC Med, 2018, 16(1):27. doi:10.1186/s12916-017-1001-7.
doi: 10.1186/s12916-017-1001-7
pmid: 29466983
|
[17] |
刘二勇, 陈明亭, 周林, 等. 开展患者关怀行动提升结核病防治综合服务质量. 中国防痨杂志, 2022, 44(5):433-437. doi:10.19982/j.issn.1000-6621.20220022.
doi: 10.19982/j.issn.1000-6621.20220022.
|
[18] |
陈晓凤, 王秀华, 聂菲菲. 肺结核患者关怀与支持干预研究进展. 中国防痨杂志, 2019, 41(7):775-778. doi:10.3969/j.issn.1000-6621.2019.07.014.
doi: 10.3969/j.issn.1000-6621.2019.07.014.
|
[19] |
Mukasa J, Kayongo E, Kawooya I, et al. Adherence to the MDR-TB intensive phase treatment protocol amongst individuals followed up at central and peripheral health care facilities in Uganda. Afr Health Sci, 2020, 20(2):625-632. doi:10.4314/ahs.v20i2.10.
doi: 10.4314/ahs.v20i2.10.
URL
|
[20] |
周扬, 卢鹏, 虞浩, 等. 耐多药肺结核患者社区管理的影响因素. 中国热带医学, 2018, 18(6):555-559. doi:10.13604/j.cnki.46-1064/r.2018.06.10.
doi: 10.13604/j.cnki.46-1064/r.2018.06.10.
|
[21] |
Gobaud AN, Haley CA, Wilson JW, et al. Multidrug-resistant tuberculosis care in the United States. Int J Tuberc Lung Dis, 2020, 24(4):409-413. doi:10.5588/ijtld.19.0515.
doi: 10.5588/ijtld.19.0515
pmid: 32317065
|
[22] |
Pradipta IS, Idrus LR, Probandari A, et al. Barriers and strate-gies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective. BMC Public Health, 2021, 21(1):1903. doi:10.1186/s12889-021-12005-y.
doi: 10.1186/s12889-021-12005-y.
|
[23] |
Chimeh RA, Gafar F, Pradipta IS, et al. Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review. Int J Tuberc Lung Dis, 2020, 24(8):811-819. doi:10.5588/ijtld.19.0754.
doi: 10.5588/ijtld.19.0754
pmid: 32912386
|
[24] |
Pradipta IS, Houtsma D, van Boven JFM, et al. Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. NPJ Prim care Respir Med, 2020, 30(1):21. doi:10.1038/s41533-020-0179-x.
doi: 10.1038/s41533-020-0179-x.
URL
|
[25] |
World Health Organization.Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
[26] |
邢伟. 重庆市耐多药结核病(MDR-TB)患者治疗依从性、管理现状及影响因素研究. 重庆: 中国人民解放军陆军军医大学, 2021.
|